U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,090 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_prepublication-draft_20120523.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  2. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide-relevo-1-5-2011.pdf
    January 01, 2011 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  3. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/module-i-ahrqs-vision-for-theory-and-principles-of-stakeholder-engagement.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  4. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/methods-guide_prepublication-draft_03-2011.pdf
    January 01, 2011 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  5. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/mrsascreening_protocol_20110602.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  6. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/decision-models-guidance-160915.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  7. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/20090427identtifyingtopics.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  8. Measuring-Blood-Pressure Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
    January 01, 2012 - Untreated or ineffectively treated hypertension leads to increased cardiovascular morbidity and mortality … the development of numerous diseases.4 Hypertension has been identified as a major risk factor for cardiovascular … Note: AE = adverse event; BP = blood pressure; CVD = cardiovascular disease; KQ = Key Question; LVH = … Most studies included individuals with uncomplicated hypertension, without recent acute cardiovascular … Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension

  9. Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/stroke-afib-update/research-2018
    May 01, 2020 - Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular … Research Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular

  10. Chapter 12: Systematic Review of Prognostic Tests | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-prognostic/methods
    December 01, 2019 - disease (<10%, 10 to 20% and >20%) based on the Framingham cardiovascular risk score to help determine … whether to recommend interventions to prevent future cardiovascular events. 34 Analyses of reclassification … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Assessing the role of circulating, genetic and imaging biomarkers in cardiovascular risk prediction. … Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality

  11. Diagnosis and Management of Gout: Current State of the Evidence | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/gout/clinician
    April 01, 2021 - swollen first metatarsophalangeal joint) and risk factors (hyperuricemia, male sex, hypertension, or >1 cardiovascular … liver function abnormalities, nausea, arthralgia, and rash Rare but serious adverse effects include cardiovascular … prophylactic agents should be considered (e.g., possible contraindications of NSAIDs in patients with cardiovascular

  12. The American College of Chest Physicians (ACCP) proposes to update the medical therapies section of 2007 updated publication on Medical Therapies for Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines.1 1.… | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-medical-therapies-section-of-2007-updated-publication-on-medical-therapies-for-pulmonary-arterial-hypertension-accp-evidence-based-clinical-practice-guidel
    November 01, 2017 - (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease, including … with the Duke Evidence-Based Practice Center, who has been selected by AHRQ to complete pulmonary and cardiovascular

  13. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
    July 01, 2012 - disease (<10%, 10 to 20% and >20%) based on the Framingham cardiovascular risk score to help determine … whether to recommend interventions to prevent 12-7 future cardiovascular events.34 Analyses of … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Assessing the role of circulating, genetic and imaging biomarkers in cardiovascular risk prediction … Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality

  14. Prognostic Tests (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Development and validation of improved algorithms for the assessment of global cardiovascular risk in … disease risk based on the Framingham cardiovascular risk score. … Development and validation of improved algorithms for the assessment of global cardiovascular risk in

  15. Prognostic Tests (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Development and validation of improved algorithms for the assessment of global cardiovascular risk in … disease risk based on the Framingham cardiovascular risk score. … Development and validation of improved algorithms for the assessment of global cardiovascular risk in

  16. Rheumatoid-Arthritis-Medicine Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Biologics neither decreased nor increased cardiovascular risks in the elderly. … Those with high- risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … Limited evidence does not suggest an increased risk of severe adverse events, including cardiovascular … Most studies found no risk of cardiovascular events and malignancy with biologic DMARDs, except for

  17. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - morbidity, hospitalization, and mortality.2 Anemia, a common complication, conveys signifi- cant risk for cardiovascular … per dL.5 A number of published studies, beginning in the late 1990s,6 suggested potential adverse cardiovascular … intermittent KD and predialysis populations appears to decline upon publication of relevant studies (e.g., Cardiovascular … Treating anemia of chronic disease in the primary care set- ting: cardiovascular outcomes and manage

  18. Mental Disorders | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/health-topics/mental-disorders?page=5
    January 01, 2005 - Abstract Archived January 1, 2005 A Multicenter, Observational Cohort Study to Assess the Cardiovascular

  19. Type-2-Diabetes-Medications-Update Surveillance (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - • For Key Question 2, conclusions regarding cardiovascular morbidity and mortality are considered … mortality, cardiovascular and cerebrovascular morbidity, retinopathy, nephropathy, and neuropathy? … The risk of cardiovascular mortality was similar between metformin and each of the thiazolidinediones … Avandia (rosiglitazone)Previous (2010-2011) FDA and MHRA warnings of cardiovascular risks (elevated … Avandia (rosiglitazone)- Previous (2010-2011) FDA and MHRA warnings of cardiovascular risks (elevated

  20. renal-update-2015-150115 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
    January 15, 2015 - lipid-lowering drugs, and antiplatelet agents are all FDA approved for hypertension and/or reduction of cardiovascular … months) including blood pressure control, preservation of kidney function, flash pulmonary edema, other cardiovascular … depict studies sought to  address key questions formulated  in  this report Abbreviation: CVD, cardiovascular … defined by authors • CHF events, including flash pulmonary edema (including hospitalization) • Other cardiovascular … calendar years enrolled, follow-up duration, hypertension and blood pressure outcomes, kidney outcomes, cardiovascular
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites